TM

Tak W. Mak

OI Ontario Cancer Institute: 11 patents #1 of 24Top 5%
UN University Health Network: 10 patents #16 of 463Top 4%
AM Amgen: 9 patents #363 of 2,867Top 15%
UN Unknown: 2 patents #12,644 of 83,584Top 20%
HS Hospital For Special Surgery: 1 patents #16 of 54Top 30%
JL John Lysaght (Australia) Limited: 1 patents #10 of 44Top 25%
CO Comcast: 1 patents #2,409 of 4,447Top 55%
📍 Toronto, CA: #126 of 9,482 inventorsTop 2%
Overall (All Time): #106,804 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 1–25 of 33 patents

Patent #TitleCo-InventorsDate
12109215 Combination therapies for inhibition of polo-like kinase 4 Jacqueline M. Mason, Mark R. Bray, Graham Fletcher 2024-10-08
11766437 Combination therapies for inhibition of TTK protein kinase Mark R. Bray, Jacqueline M. Mason, Graham Fletcher 2023-09-26
10822388 Methods and compositions for modulating toso activity Michael W. Tusche, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner +1 more 2020-11-03
10533222 Methods and compositions for detection of targets for autoimmune disease Brian Hershenfield 2020-01-14
10024844 Identification of an inhibitor of iRhom1 or an inhibitor of iRhom2 Carl Blobel, Thorsten Maretzky, David McIlwain 2018-07-17
9670265 Methods and compositions for modulating toso activity Michael W. Tusche, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner +1 more 2017-06-06
9624289 Methods and compositions for modulating Toso activity Michael W. Tusche, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner +1 more 2017-04-18
9493561 Antibodies to Toso Xiuqiu Lai, Michael W. Tusche 2016-11-15
9321824 Methods and compositions for modulating Toso activity Michael W. Tusche, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner +1 more 2016-04-26
9228006 Methods and compositions for modulating Toso activity Michael W. Tusche, Pamela S. Ohashi, Philipp Lang, Karl Lang, Dirk Brenner +1 more 2016-01-05
9132138 Method for the treatment of multiple sclerosis Gordon Duncan 2015-09-15
8309083 Polypeptides involved in immune response Steven Kiyoshi Yoshinaga, Arda Shahinian, Anna Tafuri Bladt, Giorgio Senaldi 2012-11-13
7708993 Polypeptides involved in immune response Steven Kiyoshi Yoshinaga, Arda Shahinian, Anna Tafuri Bladt, Giorgio Senaldi 2010-05-04
7482325 Downregulation of immune response by administering B7RP-2 fusion protein Steven Kiyoshi Yoshinaga, Woong-Kyung Suh 2009-01-27
7312024 Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth Ursula Kapp 2007-12-25
6664107 CD45 disrupted nucleic acid Kenji Kishihara 2003-12-16
6552246 Transgenic mice comprising CD45 knockout Josef Penninger 2003-04-22
6468528 Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth Ursula Kapp 2002-10-22
5907079 MSH2 disrupted mice develop lymphomas Armin Reitmair 1999-05-25
5786152 Methods of inhibiting syp binding to a CTLA-4 receptor Luc Edgar Joseph Marengere, David Peter Siderovski 1998-07-28
5731490 Mutant mouse lacking the expression of interferon regulatory factor 1 (IRF-1) Tadatsugu Taniguchi 1998-03-24
5714667 Mice lacking expression of CTLA-4 receptor Paul David Waterhouse 1998-02-03
5698765 Mouse having a disrupted CD4 gene 1997-12-16
5684222 Mutant mouse having a disrupted TNFRp55 1997-11-04
5675059 Mouse lacking the expression of interferon regulatory factor 2 (IRF-2) Tadatsugu Taniguchi 1997-10-07